Fairness opinions › Acquirers
Clayton, Dubilier & Rice: healthcare acquisitions with fairness opinions
2 public-company targets, 2011-2022, $7.2B combined enterprise value. The multiples Clayton, Dubilier & Rice paid and the banker analyses behind each target board's recommendation.
Deals
2
Median EV / EBITDA paid
12.1x
Median EV / revenue paid
0.96x
| Announced | Target | Acquirer | Segment | EV | EV/EBITDA | EV/Rev | DCF rate | Fairness opinion |
|---|---|---|---|---|---|---|---|---|
| 2022-05-24 | Covetrus | Clayton, Dubilier & Rice | Distribution and Equipment Services | $4.0B | 14.0x | 0.81x | 9.0%–11.5% | Goldman Sachs |
| 2011-02-14 | Emergency Medical Services | Clayton, Dubilier & Rice | Physician Groups | $3.2B | 10.2x | 1.12x | 9.5%–10.5% | Goldman Sachs |